The FDA has cleared a focused-ultrasound developer to compare the safety and efficacy of acoustic energy for treating prostate cancer against the more conservative approach of active surveillance.

An imaging OEM is teaming with a multi-omics diagnostics company to offer lung-cancer care teams lab data alongside radiologic findings and clinical histories.

One of the largest private health insurers in the U.S. has gone from considering hybrid PET/CT for cardiac indications “experimental/investigational” to displaying willingness to pay for the modality. 

A convolutional neural network has achieved 99.67% accuracy at flagging the presence of pacemakers on chest radiographs in patients referred for MRI.

Rumors have been swirling for more than a year, but a Siemens Healthineers C-suite executive has declared the company’s ultrasound business alive, well and amply resourced.

A Danish healthtech company has been cleared for European sales of AI software aimed at helping trauma physicians detect and classify fractures.

An international nonprofit medical society is teaming with a supplier of ultrasound contrast media to aid pediatric patients in Ukraine.

The capability could allow immediate alerting of CT technologists, who would adjust scan protocols or re-scan patients to optimize image quality prior to physician interpretation.